Literature DB >> 29309641

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Intraoperative Cranial Nerve Monitoring in Vestibular Schwannoma Surgery.

Esther X Vivas1, Matthew L Carlson2,3, Brian A Neff2,3, Neil T Shepard2, D Jay McCracken4, Alex D Sweeney5, Jeffrey J Olson4.   

Abstract

Question 1: Does intraoperative facial nerve monitoring during vestibular schwannoma surgery lead to better long-term facial nerve function? Target Population: This recommendation applies to adult patients undergoing vestibular schwannoma surgery regardless of tumor characteristics. Recommendation: Level 3: It is recommended that intraoperative facial nerve monitoring be routinely utilized during vestibular schwannoma surgery to improve long-term facial nerve function. Question 2: Can intraoperative facial nerve monitoring be used to accurately predict favorable long-term facial nerve function after vestibular schwannoma surgery? Target Population: This recommendation applies to adult patients undergoing vestibular schwannoma surgery. Recommendation: Level 3: Intraoperative facial nerve can be used to accurately predict favorable long-term facial nerve function after vestibular schwannoma surgery. Specifically, the presence of favorable testing reliably portends a good long-term facial nerve outcome. However, the absence of favorable testing in the setting of an anatomically intact facial nerve does not reliably predict poor long-term function and therefore cannot be used to direct decision-making regarding the need for early reinnervation procedures. Question 3: Does an anatomically intact facial nerve with poor electromyogram (EMG) electrical responses during intraoperative testing reliably predict poor long-term facial nerve function? Target Population: This recommendation applies to adult patients undergoing vestibular schwannoma surgery. Recommendation: Level 3: Poor intraoperative EMG electrical response of the facial nerve should not be used as a reliable predictor of poor long-term facial nerve function. Question 4: Should intraoperative eighth cranial nerve monitoring be used during vestibular schwannoma surgery? Target Population: This recommendation applies to adult patients undergoing vestibular schwannoma surgery with measurable preoperative hearing levels and tumors smaller than 1.5 cm. Recommendation: Level 3: Intraoperative eighth cranial nerve monitoring should be used during vestibular schwannoma surgery when hearing preservation is attempted. Question 5: Is direct monitoring of the eighth cranial nerve superior to the use of far-field auditory brain stem responses? Target Population: This recommendation applies to adult patients undergoing vestibular schwannoma surgery with measurable preoperative hearing levels and tumors smaller than 1.5 cm. Recommendation: Level 3: There is insufficient evidence to make a definitive recommendation.  The full guideline can be found at: https://www.cns.org/guidelines/guidelines-manage-ment-patients-vestibular-schwannoma/chapter_4.
Copyright © 2017 by the Congress of Neurological Surgeons

Entities:  

Keywords:  Acoustic neuroma; Auditory brainstem response; Cranial nerve monitoring; EMG; Electrophysiology; Intraoperative cranial nerve monitoring; Vestibular schwannoma

Mesh:

Year:  2018        PMID: 29309641     DOI: 10.1093/neuros/nyx513

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  8 in total

1.  Value of intraoperative monitoring of the trigeminal nerve in detection of a superiorly displaced facial nerve during surgery for large vestibular schwannomas.

Authors:  Yasmine A Ashram; Youssef M Zohdy; Tarek A Rayan; Mohamed M K Badr-El-Dine
Journal:  Neurosurg Rev       Date:  2021-09-17       Impact factor: 3.042

2.  Case Report: Extensive Temporal Bone Invasion in a Giant Vestibular Schwannoma.

Authors:  Fang Lyu; Jinlu Gan; Haijun Wang; Hongyang Zhao; Lei Wang; Fangcheng Zhang
Journal:  Front Surg       Date:  2022-05-25

3.  EANO guideline on the diagnosis and treatment of vestibular schwannoma.

Authors:  Roland Goldbrunner; Michael Weller; Jean Regis; Morten Lund-Johansen; Pantelis Stavrinou; David Reuss; D Gareth Evans; Florence Lefranc; Kita Sallabanda; Andrea Falini; Patrick Axon; Olivier Sterkers; Laura Fariselli; Wolfgang Wick; Joerg-Christian Tonn
Journal:  Neuro Oncol       Date:  2020-01-11       Impact factor: 12.300

4.  Surgical management for large vestibular schwannomas: a systematic review, meta-analysis, and consensus statement on behalf of the EANS skull base section.

Authors:  Daniele Starnoni; Lorenzo Giammattei; Giulia Cossu; Michael J Link; Pierre-Hugues Roche; Ari G Chacko; Kenji Ohata; Majid Samii; Ashish Suri; Michael Bruneau; Jan F Cornelius; Luigi Cavallo; Torstein R Meling; Sebastien Froelich; Marcos Tatagiba; Albert Sufianov; Dimitrios Paraskevopoulos; Idoya Zazpe; Moncef Berhouma; Emmanuel Jouanneau; Jeroen B Verheul; Constantin Tuleasca; Mercy George; Marc Levivier; Mahmoud Messerer; Roy Thomas Daniel
Journal:  Acta Neurochir (Wien)       Date:  2020-07-29       Impact factor: 2.216

5.  Electrophysiological mapping and assessment of facial nerve functioning during acoustic neuroma operations.

Authors:  Xiaoyu Li; Yuhai Bao; Jiantao Liang; Ge Chen; Hongchuan Guo; Mingchu Li
Journal:  Ann Transl Med       Date:  2021-03

6.  Analysis of Related Factors Affecting Facial Nerve Function after Acoustic Neuroma Surgery.

Authors:  Chunhan Liu; Yage Shen; Dongyi Han; Di Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-09       Impact factor: 2.650

Review 7.  Midline Facial Nerve Monitoring: Single-Center Experience and Review of Literature.

Authors:  Mohammed A Jomah; Eman A Hajr
Journal:  J Int Adv Otol       Date:  2022-01       Impact factor: 1.316

8.  Facial nerve function and hearing after microsurgical removal of sporadic vestibular schwannomas in a population-based cohort.

Authors:  Ismail Taha; Antti Hyvärinen; Antti Ranta; Olli-Pekka Kämäräinen; Jukka Huttunen; Esa Mervaala; Heikki Löppönen; Tuomas Rauramaa; Antti Ronkainen; Juha E Jääskeläinen; Arto Immonen; Nils Danner
Journal:  Acta Neurochir (Wien)       Date:  2019-09-07       Impact factor: 2.216

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.